News & Updates
Showing Multidisciplinary articles
Showing
Show Multimedia Only

When to resume antithrombotic therapy after GIB?
31 Aug 2026
byChristina Lau
Early resumption of antiplatelet therapy (APT) and anticoagulant therapy (ACT) ≤7 days after gastrointestinal bleeding (GIB) offers a favourable benefit–risk balance in patients with cardiovascular (CV) or cerebrovascular indications, according to a systematic review and meta-analysis conducted by researchers from the Chinese University of Hong Kong and Nanyang Technological University in Singapore.
When to resume antithrombotic therapy after GIB?
31 Aug 2026
Evolving patterns of antipsychotic use for schizophrenia over 21 years in HK
31 Aug 2026
byKanas Chan
Over the last two decades, antipsychotic prescriptions for patients with schizophrenia shifted notably toward second-generation antipsychotics (SGAs), regardless of formulation, and antipsychotic polypharmacy became more prevalent, although overall use of antipsychotics remained stable, a 21-year longitudinal study has shown.







